INTERNATIONAL PATENT: MERCK PATENT GMBH, ARTIOS PHARMA LIMITED FILES APPLICATION FOR "HETEROCYCLIC COMPOUNDS MODULATING EXONUCLEASE 1 (EXO1)"

GENEVA, Aug. 25 -- MERCK PATENT GMBH (Frankfurter Strasse 25064293 Darmstadt), ARTIOS PHARMA LIMITED (Babraham HallBabraham Research CampusCambridge CB22 3AT) filed a patent application (PCT/GB2025/050273) for "HETEROCYCLIC COMPOUNDS MODULATING EXONUCLEASE 1 (EXO1)" on Feb 13, 2025. With publication no. WO/2025/172707, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BURGDORF, Lars (c/o Merck Patent GmbHFrankfurter Strasse 25064293 Darmstadt), NEFF, Bernd (c/o Merck Patent GmbHFrankfurter Strasse 25064293 Darmstadt), FOLLO...